Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP/GLP-1 receptor agonist that has generated interest regarding its potential effects on erectile dysfunction
RESEARCH LIQUIDS Our products are intended for laboratory research only and are not for human consumption, as outlined in our terms and conditions
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities
Additional Potential Benefits of CJC-1295 Growth Hormone Secretagogue: As a growth hormone secretagogue, CJC-1295 stimulates the pituitary gland to release more growth hormone, contributing to various health benefits
#NatureCommunications #CardiovascularHealth #NutritionScience #GutHealth #ClinicalResearch #HealthInnovation #Cholesterol #MetabolicHealth #WellnessResearch To view or add a comment, sign in Strawberries and prediabetes: a natural ally against insulin resistance
Its complex structure, like that of other advanced peptides such as Tirzepatide or Semaglutide, is precisely why gentle handling is so crucial